Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients

NCT03362073 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Ketamine
Refractory Cancer Pain

Interventions

DRUG: Ketamine

Sponsor

Pusan National University Yangsan Hospital